Umkehrer, C
Ahn (Johns Hopkins University) for study administration and data collection
Notably, potential biomarkers such as 11,12-epoxyeicosatrienoic acid (AUC = 0.964) and MG (PGF2alpha/0:0/0:0) (AUC = 0.953) are implicated in pathophysiological mechanisms of MMA and its standard treatment through their association with inflammation, oxidative stress, and altered fatty acid metabolism
Microglial TLR9 stimulation increases production of pro-inflammatory cytokines and chemokines, while astrocytic activation contributes to gliosis and release of neurotoxic mediators
These do not represent typical outcomes, and results vary
Sources Novo Nordisk: Ozempic Pricing Novo Nordisk: Wegovy Pricing Novo Nordisk: Rybelsus Pricing Healthinsurance.org: Does health insurance cover drugs used for weight loss such as Ozempic, Wegovy, Mounjaro, and Zepbound